Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Digital Health Event 2021

Integrating multimodal data to meet clinical challenges 

Tuesday 19th October 2021 | 10:30 – 11:45 P.M. ET

Register now 

 

Summary

With the ubiquity of smartphones and wearables, studies no longer have to be designed to simulate situations as a proxy for a person’s lived experience. Instead, clinical assessments can be interwoven into patients’ day-to-day lives on their day-to-day devices. This means that trials can be: 

  • Delivered remotely, supporting patients to engage with researchers who may otherwise struggle to attend sites, for a more inclusive and representative study 
  • Multimodal to generate a richer picture of the fluctuations in patient wellbeing, and ultimately move towards sustained improvements  
  • Tracking the benefits of an intervention in patients’ everyday lives, pulling focus on what matters most to patients e.g. the ability to undertake their day-to-day activities   

Join us for a discussion on how technology can support the transition from demonstrating efficacy in the lab to delivering effective and acceptable treatments in the long term. 

 

Expert speakers

We are pleased to have the following prominent speakers who are working actively in the fields of drug development and digital health: 

Valeria De Luca, Data Scientist at Novartis

Valeria De Luca is associate director and senior principal data scientist at the Novartis Institutes for Biomedical Research, where she works on multi-modal data-driven approaches to quantify patient’s response to disease and treatment. Prior to joining Novartis in 2017, she was a postdoctoral research fellow at UCSF and ETH Zurich focusing on predictive models for critical care. She holds a PhD in Computer Vision from ETH Zurich on personalized cancer treatments.

Fai Ng, Professor of Rheumatology at Newcastle University and IDEA-FAST Leader

Fai Ng is Professor of Rheumatology at Newcastle University and Honorary Consultant Rheumatologist at the Newcastle upon Tyne NHS Foundation Trust. He is an international leader in primary Sjögren’s syndrome (PSS) research. Fai established the UK primary Sjögren’s syndrome registry (www.sjogrensregisty.org), one of the world’s largest PSS cohorts and biobanks. Fai also leads the NIHR Bioresource Centre in PSS.

Fai is also the the coordinator of the IDEA-FAST consortium, a project aiming to identify digital endpoints that provide reliable, objective and sensitive evaluation of activities of daily life, disability and health related-quality of life for a range of neurodegenrative diseases.

Ieuan Clay, Director, Chief Scientific Officer, Digital Medicine Society (DiMe)

Ieuan Clay joined the Digital Medicine (DiMe) society in 2021 as Chief Scientific Officer, where he is responsible for scientific strategy and output. He lectures at ETHZ and FHNW in Digital Health, and is an editor at Karger Digital Biomarkers. Following his PhD at the University of Cambridge which focused on technology and analytics development, he joined Novartis Research in 2010, where he built and led the Digital Endpoints group within Translational Medicine (early clinical portfolio). In 2019, he joined Evidation Health, initially focusing on research strategy and then joining commercial to help build their Heart Health on Achievement health programs in collaboration with the American College of Cardiology. 

 

Francesca Cormack, Director of Research and Innovation at Cambridge Cognition

Francesca is Director of Research and Innovation at Cambridge Cognition. She has extensive experience of statistics, cognitive neuroscience and cognitive test development in a range of clinical populations. Since joining Cambridge Cognition in 2014, Francesca has worked to develop novel cognitive testing methodology to support high-frequency, near patient testing using digital technology, providing researchers and healthcare providers with unique insights into cognitive health.  

Francesca obtained a PhD in Dementia with Lewy Bodies at Newcastle University, followed by post-doctoral and academic positions at University College London and at the Medical Research Council in Cambridge. She maintains academic collaborations focused on neurological disorders, ageing and dementia.

Chair: Anzar Abbas, Director of Digital at Cambridge Cognition  

Anzar Abbas, PhD is a neuroscientist focused on developing technology to improve measurement of health, increase access to care, and inform clinical decision-making using data-driven insights. He is Director of Digital Solutions at Cambridge Cognition, where he serves as a subject matter expert on the implementation of digital measurement in clinical research and practice. Anzar received his doctorate in Neuroscience from the Laney Graduate School at Emory University. 

Agenda (ET)

10:30 – 10:35: Introductions  
10:35 – 11:15: Presentations  
11:15 – 11:45: Panel discussion  

 

Who should attend?

Professionals from biotech, pharmaceutical, CRO, healthcare and technology industries who work in:  

  • Drug development 
  • Medical affairs 
  • Clinical operations 
  • Clinical innovation 
  • Patient engagement 
  • Virtual trials 
  • Digital strategy 
  • Digital biomarkers  

 

Questions

This is an interactive event so please submit your questions for the speakers and share your lessons learned delivering digital endpoints.  

Register now 

Share this